Date of Submission


Degree Type


Degree Name

Doctor of Psychology (PsyD)



Department Chair

Stephanie H. Felgoise, PhD, ABPP

First Advisor

Michelle R. Lent, PhD

Second Advisor

Patrick McElwaine, PsyD

Third Advisor

Barbara A. Golden, PsyD, ABPP


Despite the widespread attention and resources allocated to the current opioid crisis, the public health problem persists. A major target in the efforts to combat the opioid crisis is increased accessibility and utilization of medications for opioid use disorder (MOUD). A robust body of evidence supports the effectiveness of medications to treat opioid use disorder (OUD) in reducing overdose deaths and improving overall outcomes. Yet, MOUD continues to be underutilized at alarming rates. Studies have discovered that only one-third of substance use disorder (SUD) treatment sites offer any form of MOUD and approximately 30% of individuals with OUD receive any form of MOUD. A potential barrier to MOUD utilization that has not been thoroughly examined is how OUD treatment providers perceive medications for OUD. Clinicians and researchers, including counselors and psychologists, are not able to prescribe medications but may have an influence on the individual seeking treatment for OUD. Clinicians have significant influence on clients’ determination of treatment options and, knowingly or unknowingly, can promote or discourage MOUD. The present study examines survey data collected from mental health professionals that either conduct research with or provide direct clinical care to individuals with OUD. The present study aims to analyze perceptions of MOUD between groups of clinicians and researchers working with OUD, years of experience in the OUD field, and varying occupational settings. Results from the study will help to fill gaps in the literature about healthcare professionals’ perceptions towards MOUD and the degree to which they may serve as a barrier to its acceptance and implementation.

Included in

Psychology Commons